We strategically
create future
medical solutions.

Our company name, MedBeStrat®,
is derived from the concept of
"Medical solutions are to
be strategically created."

Contact

Mission

Continue to provide innovative and comprehensive problem-solving solutions. as a bridge between pharmaceutical and healthcare companies and patients, through medical marketing*

*“Medical Marketing” maximizes the true value of the products and services of pharmaceutical and healthcare companies through use of scientific evidence, understanding market needs, and appropriately delivering them to medical professionals and patients. Our vision is to become a strategic partner through this practice and contribute to the realization of patient-centric medical care and the sustainable growth of pharmaceutical and healthcare companies.

Vision

Become the most trusted partner of pharmaceutical and healthcare companies, to pioneer the future of patient-centered medical care.

Core Values

  • 1. Patient CentricWe place patients at the center of all our ideas and actions.
  • 2. StrategicWe ensure to understand the needs and provide the best direction and solutions.
  • 3. CreativeWe offer innovative approaches that are not bound by conventional frameworks.
  • 4. ProfessionalWe utilize our deep knowledge and experience in pharmaceuticals and healthcare.
  • 5. Honest and TransparentWe commit to high ethical standards and ensure transparent communication.
Contact

Key Business Description

Consulting/Project Support

  • symbol icon

    Medical Marketing strategy

  • symbol icon

    Regulatory approval strategy

  • symbol icon

    Holistic product launch strategy

  • symbol icon

    Pricing and HTA* strategies

  • symbol icon

    Organization strategy

  • symbol icon

    Quality assurance and supply chain strategies

  • symbol icon

    Evidence generation and publication strategies

  • symbol icon

    Digital transformation strategy

  • symbol icon

    Sales strategy

  • symbol icon

    Business feasibility assessment

*HTA: Health Technology Assessment

MedBeStrat® Consulting Services

We provide strategic consulting services to help launch pharmaceuticals and healthcare products.

service flow

Features of Our Consulting

  • Practical and feasible support backed by our 35+ years of experience and achievements:

    Based on our 35+ years of field and management experience of sales and marketing as well as research and medical functions in pharmaceutical industry, we provide a more practical and feasible consulting support that our peers do not have.

  • Building a comprehensive strategy through the integration of diverse expertise:

    We build comprehensive strategies by forming teams with not only those in sales and marketing, research, and medical fields but also a variety of alliance partners. We address silo issues (e.g., division of labor between commercial and medical departments due to regulations) and support overall organizational productivity by pursuing cross-departmental synergies.

  • Flexible approaches to a wide variety of client’s needs:

    We propose innovative tailored solution approaches to all companies, from startups to large scale pharmaceutical companies, throughout their various growth stages, by drawing on our experience in flexible strategy planning and implementation.

Who we can help

  • Pharmaceutical/healthcare companies in Japan:

    planning to launch a product in a new disease area, but do not have enough resources in sales, marketing and medical activities in order to develop strategic launch readiness plans.

  • Pharmaceutical/healthcare companies outside Japan:

    considering to enter the Japanese market from overseas, would like strategic advice regarding negotiations with Japanese regulatory authorities and preparations for market launch.

  • Non-pharmaceutical/healthcare companies:

    thinking of entering pharmaceutical or healthcare industry and would like advice on laws and regulations, business practices, etc., as well as strategic support for launching a product.

  • Any company:

    needing early product evaluation and market research analysis in the pharmaceutical or healthcare field.

MedBeStrat® Consulting Flow

  1. Survey and Analysis

    Clarify issues through interviews with clients and analyze the current state of the market and products

  2. Strategy Proposal

    Propose optimal strategies and execution plans based on analysis results

  3. Project Management
    and Execution Support

    Collaborate with clients and support the delivery and management of the project according to the plan

  4. Monitoring and
    Evaluating Outcomes

    Monitor outcomes after launch and during the implementation and suggest continuous optimization

  5. Follow-up
    and Feedback

    Support sustainable growth with continuous follow-up and feedback for future development

Contact

Introduction of Executives

  • Yukiya Suzuki

    Representative Director, President

    Yukiya Suzuki, MS, MBA

    Mr. Suzuki has an exemplary career that spans major pharmaceutical companies such as Yamanouchi / Astellas and Amgen , as well as innovative startups like Amgen Astellas Biopharma and PharmaEssentia, both in Japan and internationally. Specializing in urology, hematology/oncology, bone/inflammation, hyperlipidemia, and rare diseases, he brings extensive experience in sales and marketing across a wide range of therapeutic areas. Mr. Suzuki has successfully led the launches of over 10 products, demonstrating a robust track record in achieving market penetration. His leadership extends beyond individual product launches, encompassing the successful management of numerous cross-functional projects focused on launch preparation, post-launch activities, business process optimization, operational excellence, departmental integration, drug pricing strategies, and digital transformation (DX) initiatives. He has a strong academic foundation, holding both an MS in Pharmaceutical Sciences and an MBA.

  • Naoki Agata

    Director, Executive Vice President

    Naoki Agata, PhD

    Dr. Agata boasts a distinguished career spanning both major pharmaceutical companies (Pfizer, AbbVie, Shire) and innovative startups (Guardant Health, PharmaEssentia) in Japan and overseas. His expertise encompasses drug discovery across oncology, immunology, and rare diseases, with a focus on both early-stage research at renowned institutions (Stanford University, Dana-Farber Cancer Institute) and translational efforts at companies like ILEX Oncology and Genzyme. He has a proven track record of success in bringing numerous pharmaceuticals and diagnostics to market, with extensive experience in medical affairs, market access (pricing, HTA, patient support), and business development. He maintains a strong academic presence, having served on the editorial board of the AACR journal Molecular Cancer Therapeutics and as a council member of the Japan Pharmacological Society. He currently serves as a visiting professor at Toho University. He holds a Ph.D. in Pharmaceutical Sciences from Kanazawa University.

MedBeStrat® Alliance Members

We will tailor project teams with our alliance partners to meet your specific needs.

  • Gaku Sasaki

    Business Insights

    Gaku Sasaki

    Senior Executive Officer
    Seed Planning, Inc.

    With 30 years of experience in market research and insight consulting within healthcare industries, he has held senior roles at SSRI and INTAGE Healthcare. He has supported global companies with strategies for new markets, early development assessments, market launches, and lifecycle management. He has been in his current role since 2020.

  • Toshiyuki Kogawa

    Business Value Optimization

    Toshiyuki Kogawa

    President, Healthcare BizValue

    Professional with extensive experience as Business Strategy Head and Commercial Head of New Business at Astellas Pharma. Lead business valuation for strategic decision-making, develop product and portfolio strategy and realize commercialization framework.
    Established Healthcare BizValue in 2022.

  • Hideki Maeda

    Regulatory Sciences

    Hideki Maeda, PhD

    Professor
    Meiji Pharmaceutical University

    MS (Pharmaceutical Sciences) from Osaka University and PhD (Pharmaceutical Sciences) from Keio University. Engaged in clinical development and medical affairs at Astellas Pharma Inc. for many years, and assumed the current position in 2019. Executive member of the Anti-Tumor Drug Development Forum, councilor of the Society for Regulatory Science, and the Japanese Society of Medical Oncology, representative member of the Pharmaceutical Society of Japan, and board member of the Japan Society for Pharmacoepidemiology.

  • Hiroshi Ogawara

    Supply Chain

    Hiroshi Ogawara

    With extensive experience as a responsible person at both domestic and international pharmaceutical companies and venture firms, he has been deeply involved in pharmaceutical production and quality assurance for many years. Leveraging this hands-on expertise, he is dedicated to providing tailored consulting services and support to address the various challenges associated with establishing a Japanese corporation, securing manufacturing and sales approvals, and successfully launching new products in the Japanese market.

  • Takeo Higata

    Human Resources Development

    Takeo Higata

    Training Consultant
    Representatve of SalesTrainingLabo

    As a lead of talent development team at GlaxoSmithKline, Biogen, and Amgen, involved in skill and leadership development of MRs, 1st line and 2nd line sales managers, marketing staff, and the launch of new organizations. SalesTrainingLabo became fully operational in 2024. Book: “Ten Questions for those who wish to be successful MR (Medical Representative)” 2024, Learnings Publishing.

  • Aiko Yamamoto

    Marketing

    Aiko Yamamoto

    President, A-CONNEX

    Experienced pharmaceutical professional with a background in MR and marketing at Astellas, following pharmaceutical consulting. Specialized in oncology and CAR-T cell therapy new product planning, business development, and marketing leadership for a therapeutic application at GSK and Novartis. Founded a consulting firm in 2024. Pharmacist, MBA.

  • Yasuhito Terui

    Clinical Medicine

    Yasuhito Terui, MD, PhD

    Professor, Department of Hematology, Saitama Medical University Hospital, Saitama Medical University International Medical Center Senior Executive Officer Seed Planning, Inc.

    MD from Jichi Medical University and PhD (Medicine) from Jichi Medical University Graduate School.　
    Board certified doctor of Japanese Society of Internal Medicine (general internal medicine), Japanese Society of Hematology, and Japanese Society of Medical Oncology. Director of The Japanese Onco-Cardiology Society, and The Japanese Association for  Molecular Target Therapy of Cancer.

  • Tatsuo Shimosawa

    Clinical Medicine

    Tatsuo Shimosawa, MD, PhD

    Professor, Department of Clinical Laboratory MedicineInternational University of Health and Welfare Graduate School of Medicine

    MD from Tsukuba University and PhD (Medicine) from Tokyo University School of Medicine.Board certified doctor of Japanese Society of Internal Medicine (general internal medicine), Japanese Society of Clinical Laboratory Medicine, Japanese Society of Hypertension, Japan Endocrine Society, Japan Geriatrics Society. Fellow of the American Heart Association and the International Society of Hypertension. Director of Japanese Society of Hypertension and Japanese Society of Clinical Laboratory Medicine. Vice President of the Japan Clarinet Association.

Company Profile

Name
MedBeStrat® Co., Ltd.
Founded
December 4, 2024
Head Office
Nihonbashi Oedo Bld. #613, 2-5-6,
Nihonbashi Kayaba-cho ,
Chuo-ku , Tokyo 103-0025, Japan
Contact
             
contact@medbestrat.com
Directors
Yukiya Suzuki (Representative Director, President)
Naoki Agata (Director, Executive Vice President)
Stated Capital
6 million yen
Business
Consulting services focusing on business strategies and medical
marketing for pharmaceuticals, healthcare products, etc.
Contact